###begin article-title 0
###xml 68 73 <span type="species:ncbi:10090">Mouse</span>
Induced Prion Protein Controls Immune-Activated Retroviruses in the Mouse Spleen
###end article-title 0
###begin p 1
Conceived and designed the experiments: ML LH. Performed the experiments: MG PS MR JB KL ML AN LH RS. Analyzed the data: MR JB KL ML RS. Contributed reagents/materials/analysis tools: RZ MG PS MR JB KL ML AN LH. Wrote the paper: RZ MG MR JB ML.
###end p 1
###begin p 2
Current address: CSL Behring AG, Bern, Switzerland
###end p 2
###begin p 3
Current address: Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
###end p 3
###begin p 4
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 578 584 <span type="species:ncbi:10090">murine</span>
The prion protein (PrP) is crucially involved in transmissible spongiform encephalopathies (TSE), but neither its exact role in disease nor its physiological function are known. Here we show for mice, using histological, immunochemical and PCR-based methods, that stimulation of innate resistance was followed by appearance of numerous endogenous retroviruses and ensuing PrP up-regulation in germinal centers of the spleen. Subsequently, the activated retroviruses disappeared in a PrP-dependent manner. Our results reveal the regular involvement of endogenous retroviruses in murine immune responses and provide evidence for an essential function of PrP in the control of the retroviral activity. The interaction between PrP and ubiquitous endogenous retroviruses may allow new interpretations of TSE pathophysiology and explain the evolutionary conservation of PrP.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Chesebro1">[1]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Bueler1">[2]</xref>
###xml 542 545 542 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Prusiner1">[3]</xref>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Caughey1">[4]</xref>
###xml 827 835 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 867 870 867 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Deleault1">[5]</xref>
###xml 154 160 <span type="species:ncbi:9606">humans</span>
###xml 162 168 <span type="species:ncbi:9913">bovine</span>
###xml 204 210 <span type="species:ncbi:9913">cattle</span>
###xml 223 228 <span type="species:ncbi:9940">sheep</span>
###xml 233 238 <span type="species:ncbi:9925">goats</span>
The prion protein (PrP) is essential for the susceptibility to transmissible spongiform encephalopathies (TSE) such as Creutzfeldt-Jacob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep and goats, and chronic wasting disease (CWD) in deer and elk [1]. In the absence of PrP, TSE symptoms do not develop [2], and the accumulation of misfolded PrP in diseased tissue is a hallmark of TSE. According to the widely accepted protein-only hypothesis, misfolded PrP itself constitutes the infectious agent [3]. Yet, this dogma awaits to be proven and is challenged by strong evidence for the involvement of non-PrP molecules as "partners in crime" [4]. A recent study demonstrated that synthetic poly(A) RNA, added to purified native hamster PrP, is a sufficient stoichiometric cofactor for in vitro amplification of misfolded PrP [5].
###end p 6
###begin p 7
###xml 496 504 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 708 716 708 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 830 833 830 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Prusiner1">[3]</xref>
###xml 962 965 962 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Deleault2">[6]</xref>
###xml 1051 1059 1051 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1253 1256 1253 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Sayer1">[7]</xref>
###xml 1258 1261 1258 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Weiss1">[8]</xref>
###xml 1427 1430 1427 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Weissmann1">[9]</xref>
###xml 1432 1436 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Nishida1">[10]</xref>
###xml 1487 1495 1487 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Remarkably, hamsters inoculated with samples obtained by these amplification experiments developed TSE. Rather unexpectedly though, the disease occurred not only with samples from amplification that had been initiated by a seed of misfolded PrP originating from diseased hamster brain, but likewise with samples from amplification that had started spontaneously, i.e. in the absence of an initial TSE seed. Moreover, strain characteristics of TSE caused with inoculum from seeded and spontaneous in vitro amplification were undistinguishable, but they differed from TSE caused with inoculum of misfolded PrP that was used to seed amplification. Hence, TSE strain characteristics of the inoculum generated by in vitro amplification seemed to be imprinted not by a seed of misfolded PrP, as the protein-only hypothesis would entail [3], but rather by the accessory poly(A) RNA. The putative role of RNA in TSE is also supported by a related study reported earlier [6], where the accessory component extractable from tissue homogenate and sufficient for in vitro amplification of misfolded PrP was recognized to be particular RNA. By other researchers, RNA aptamers specifically interacting with native or misfolded PrP were isolated by in vitro selection [7], [8]. This indicates that in complex mixtures, RNA species may compete for binding to PrP conformers, which could be the basis for TSE strain formation and interferences [9], [10]. However, despite the evidence gained by means of in vitro experiments for a cofactor role of RNA in TSE, no TSE-specific RNA has ever been identified. Therefore, the roles of PrP and possible cofactors in TSE have remained controversial.
###end p 7
###begin p 8
###xml 330 333 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Caughey1">[4]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Westergard1">[11]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Bendheim1">[12]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Wopfner1">[13]</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Bueler2">[14]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Richt1">[15]</xref>
The physiological function of PrP might be a key towards better understanding TSE pathophysiology. Numerous reports from the past two decades proposed various physiological roles of PrP in processes as diverse as copper homeostasis, leukocyte differentiation or neuritogenesis, indicating that PrP may serve more than one purpose [4], [11]. In addition, PrP is a broadly expressed and highly conserved gene product [12], [13], suggesting that susceptibility to TSE, which could be considered a negative selection criterion for this protein, is outweighed by a vital function of PrP. Though, this view is in harsh contrast with observations that PrP seems to be dispensable for normal development and health of individual mammals [14], [15]. Up to date, no concept has emerged that would reconcile the conflicting aspects of this enigmatic protein.
###end p 8
###begin p 9
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 358 364 <span type="species:ncbi:10090">murine</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
We have recently described an up-regulation of PrP in the germinal centers of mouse spleens following immune-stimulation [16]. Although this regulation is suggestive of an immunological role of PrP, no consequences of the increased PrP level could be demonstrated. Here we report that PrP up-regulation occurs in response to massive appearance of endogenous murine retroviruses in the germinal centers upon immune-stimulation. We show that elevated PrP expression helps to reduce the retroviruses to the level before their activation, whereas in the absence of PrP virus abundance persists. Hence, we have identified in the mouse a key role of PrP in the control of activated endogenous retroviruses. Our findings may resolve the aforementioned conflict in the conception of PrP function and suggest a plausible candidate for an RNA species possibly involved in TSE.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 46 52 <span type="species:ncbi:10090">murine</span>
Co-localized massive appearance of endogenous murine retroviruses and increased PrP expression in immune-stimulated splenic FDC networks
###end title 11
###begin p 12
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 629 638 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s001">Figure S1</xref>
###xml 806 815 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g001">Figure 1A</xref>
###xml 1044 1053 1044 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g001">Figure 1A</xref>
###xml 1211 1220 1211 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s001">Figure S1</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 81 107 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 109 112 <span type="species:ncbi:11276">VSV</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 874 877 <span type="species:ncbi:10116">rat</span>
###xml 930 936 <span type="species:ncbi:10090">murine</span>
Splenic PrP up-regulation was observed 8 days after infection of naive mice with vesicular stomatitis virus (VSV) or intravenous administration of preformed immune complexes [16]. By immunofluorescence staining, up-regulated PrP was detected in the network of follicular dendritic cells (FDC), but its exact localization with respect to FDC dendrites and adjacent lymphocytes remained unknown. Therefore, we examined splenic germinal centers of immune-stimulated mice by transmission electron microscopy (TEM). Staining of ultrathin sections with PrP specific antibodies yielded an immunogold labeling confined to FDC dendrites (Figure S1). Surprisingly, dendrites of immune-stimulated and PrP-expressing FDC were decorated with numerous electron-dense, enveloped particles resembling type C retroviruses (Figure 1A). Their retroviral nature was assessed by staining with a rat antibody specific for the envelope protein (Env) of murine leukemia retroviruses (MLV), resulting in an immunogold labeling on the outer face of the virus particles (Figure 1A inset). In contrast to Env, no PrP presence was revealed in the viral particles, despite morphological evidence for MLV budding from the PrP-expressing FDC (Figure S1).
###end p 12
###begin title 13
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
Microscopic revelation of numerous MLV particles in FDC network with increased PrP expression after immune-stimulation of a C57Bl/6 mouse with IC.
###end title 13
###begin p 14
###xml 630 636 <span type="species:ncbi:9986">rabbit</span>
###xml 664 667 <span type="species:ncbi:10116">rat</span>
(A) Ultrastructure of splenic FDC revealed by TEM. Large panel displays plastic section 70 nm thin, showing lymphocytes with dark round nuclei (L), and part of an FDC with lobate nucleus (F) and labyrinthine extensions. Small dark spots (arrows) on FDC extensions represent viral particles. Bar, 2.5 microm. Inset shows cryosection 90 nm thin, depicting viral particles on FDC extension. Dot-like gold particles represent immunostaining specific for MLV Env protein. Bar, 0.5 microm. (B) Co-localized immunofluorescence staining of PrP and MLV Env in splenic germinal center. Semithin (400 nm) cryosection was double-stained with rabbit serum specific for PrP and rat monoclonal antibody specific for MLV Env. Bar, 25 microm.
###end p 14
###begin p 15
###xml 240 249 240 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s002">Figure S2</xref>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g001">Figure 1B</xref>
In fluorescence microscopy, three different antibodies specific for MLV envelope glycoprotein and capsid protein p30, respectively, labeled structures on spleen cryosections that co-localized to FDC networks with strong PrP immunostaining (Figure S2). Whereas MLV staining appeared granular, PrP staining seemed continuous along the FDC dendrites (Figure 1B).
###end p 15
###begin p 16
###xml 402 411 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figure 2A</xref>
###xml 709 718 709 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s003">Figure S3</xref>
###xml 97 100 <span type="species:ncbi:11276">VSV</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
We used the p30-specific antibody for Western blot analysis of spleen homogenates from naive and VSV-infected C57BL/6 mice to assess whether the observed MLV particles were associated with the formation of mature p30 protein. In addition to the characteristic band at 30 kDa observed after immune-stimulation, the anti-p30 staining revealed precursor forms of p30 in all tested C57BL/6 spleen samples (Figure 2A). To assure that the 30 kDa band of p30 protein was representative for mature MLV, the activity of reverse transcriptase (RT) in the spleen homogenates was analyzed. The RT activities, as detected by product-enhanced RT (PERT) assay, strictly correlated with the respective p30 signals at 30 kDa (Figure S3). This validated p30-specific immunoblot analysis as a tool to estimate the abundance of matured MLV in splenic tissue.
###end p 16
###begin title 17
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Immunoblots showing increase of PrP and mature MLV p30 in spleens of immune-stimulated mice.
###end title 17
###begin p 18
###xml 1063 1066 1063 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 113 116 <span type="species:ncbi:11276">VSV</span>
###xml 120 124 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 467 470 <span type="species:ncbi:11276">VSV</span>
###xml 522 526 <span type="species:ncbi:10090">Mice</span>
###xml 586 589 <span type="species:ncbi:11276">VSV</span>
###xml 734 737 <span type="species:ncbi:11276">VSV</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
(A) Comparison of PrP and mature p30 abundance following various immune-stimuli. C57Bl/6 mice were infected with VSV or LCMV, or treated with thioglycolate (TG) or lipopolysaccharide (LPS). Eight days after immune-stimulation spleen homogenates were analyzed by Western blot for PrP (upper panels) and p30 (lower panels). Representative blots are shown. Protein bands revealing mature p30 protein are boxed. (B) Capacity of various inbred mouse strains to respond to VSV infection with increased abundance of PrP and p30. Mice of the strains DBA/2, BALB/c and 129/Sv were infected with VSV. Splenic PrP and MLV p30 were analysed on day 8 after infection. Representative blots are shown. (C) Kinetic of PrP and p30 abundance following VSV infection. Spleens of C57BL/6 mice were analyzed on day 0, 3, 5, 8 and 14, respectively, after infection. In the presented Western blots homogenates of three spleens per time point group were pooled for analysis, in order to obtain averaged results. (D) Different kinetics of PrP and p30 abundance in 129/Sv, C57BL/6 and Prnp-/- (Nagasaki) mice. Spleens were analyzed on day 0, 8 and 30, respectively, after infection. Per experimental group homogenates of three spleens were pooled.
###end p 18
###begin p 19
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figure 2A</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 707 717 707 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figures 2B</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g004">4A</xref>
###xml 765 774 765 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figure 2B</xref>
###xml 920 933 920 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figure 2B, 2D</xref>
###xml 935 936 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g003">3</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g004">4A</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 78 112 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
###xml 114 118 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 636 639 <span type="species:ncbi:11276">VSV</span>
###xml 850 853 <span type="species:ncbi:11276">VSV</span>
Additional Western blot analyses revealed that infection of C57BL/6 mice with lymphocytic choriomeningitis virus (LCMV) and administration of thioglycolate or lipopolysaccharide (LPS) also activated endogenous retroviruses (Figure 2A). The broad spectrum of effective immune-stimuli suggested that PrP up-regulation and MLV appearance were consequences of activated adaptive and innate mechanisms of resistance. This is consistent with the fact that splenic PrP up-regulation is dependent on the complement component C1q [16]. Similar to C57BL/6 mice, DBA/2 and BALB/c mice showed augmented MLV activity following immune-stimulation by VSV infection as assessed by p30 Western blot analysis and PERT assay (Figures 2B and 4A), and responded with PrP up-regulation (Figure 2B). In contrast, 129/Sv did not show increased retrovirus activity following VSV immune-stimulation and also failed to up-regulate PrP expression (Figure 2B, 2D, 3, and 4A).
###end p 19
###begin title 20
Immunohistochemistry illustrating the interdependence of PrP and IMERV in the splenic FDC network.
###end title 20
###begin p 21
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 137 140 <span type="species:ncbi:11276">VSV</span>
###xml 197 203 <span type="species:ncbi:9986">rabbit</span>
###xml 243 247 <span type="species:ncbi:9925">goat</span>
Frozen spleen sections representing 129/Sv wild-type, C57Bl/6 wild-type and Prnp-/- (Nagasaki) mice on C57Bl/6 background, infected with VSV for 0, 8 and 30 days. Sections were double-stained with rabbit serum specific for PrP (upper row) and goat serum specific for MLV p30 (lower row). Bar, 100 microm.
###end p 21
###begin title 22
Quantification of splenic IMERV activity.
###end title 22
###begin p 23
###xml 766 769 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 53 <span type="species:ncbi:11276">VSV</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 349 352 <span type="species:ncbi:11276">VSV</span>
###xml 480 483 <span type="species:ncbi:11276">VSV</span>
###xml 628 631 <span type="species:ncbi:11276">VSV</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
Open plot symbols represent naive, filled symbols VSV-infected C57Bl/6 (square,blacksquare, square, filled), BALB/c (triangle up,black triangle), DBA/2 (triangle down,black triangle down) or 129/Sv (o,*) mice. Short horizontal lines indicate average values of respective experimental categories. (A) RT activity in spleen homogenates on day 8 after VSV infection, as revealed by PERT assay. (B) Relative abundance of RNA with IMERV-1 and IMERV-2 specific sequences on day 8 after VSV infection, as assessed by real-time RT-PCR on total splenic RNA. (C) Relative abundance of mature MLV p30 in spleen homogenates on day 30 after VSV infection, as determined by densitometric quantification of immunoblots. Samples were obtained from C57Bl/6 wild-type mice (+/+), Prnp-/- (Nagasaki) mice (-/-) and F1 offsprings of a crossing of the former two lines (+/-).
###end p 23
###begin title 24
Partial sequence identification of immune-stimulated MLV
###end title 24
###begin p 25
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Jenkins1">[17]</xref>
###xml 671 678 671 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001158-t001">Table 1</xref>
###xml 874 883 874 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g004">Figure 4A</xref>
###xml 1053 1062 1053 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s004">Figure S4</xref>
###xml 1459 1460 1459 1460 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</bold>
###xml 1476 1477 1476 1477 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</bold>
###xml 1483 1484 1483 1484 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 1494 1495 1494 1495 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</bold>
###xml 1499 1500 1499 1500 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</bold>
###xml 1706 1715 1706 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g004">Figure 4B</xref>
###xml 1829 1838 1829 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g004">Figure 4B</xref>
###xml 1960 1967 1960 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001158-t001">Table 1</xref>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 767 772 <span type="species:ncbi:10090">mouse</span>
###xml 1476 1482 <span type="species:ncbi:10090">murine</span>
###xml 1922 1926 <span type="species:ncbi:10090">mice</span>
###xml 1954 1958 <span type="species:ncbi:10090">mice</span>
###xml 2026 2030 <span type="species:ncbi:10090">mice</span>
Since the most likely origin of the observed MLV particles is the activation of proviral genes, 129/Sv might lack these particular proviruses, in analogy to the reported paucity of AKR-like proviruses in mouse 129 strains [17]. Clarification of this issue was expected from the identification of MLV-specific proviral genes involved in the observed appearance of MLV particles in immune-stimulated mouse spleens. First, we analyzed total splenic RNA using real-time RT-PCR with a primer-probe set of broad specificity for MLV-related RNA sequences. All spleen samples tested positive for MLV RNA, without significant differences between naive and immune-stimulated mice (Table 1). This result most likely reflected the general abundance of MLV-related RNA species in mouse spleens, as indicated already by the notable RT "background" activity level of naive spleen lysates (Figure 4A). Therefore, we isolated MLV particles from immune-stimulated spleen tissue by Env-specific immunoadsorption and subsequently extracted the particle-associated MLV RNA (Figure S4). Complementary DNA corresponding to the purified MLV RNA was amplified and subcloned. From the subcloned PCR products two sequences of 732 nucleotides each were identified. They are homologous to published MLV-related sequences in the NCBI GenBank, with accession number U63133 (nucleotide range 2058-2789) and X94150 (range 2061-2792), respectively. Because these sequences seemed to represent immune-activated murine endogenous retroviruses, we named them IMERV-1 (homologous to U63133) and IMERV-2 (X94150). Their up-regulation upon immune-stimulation was confirmed by real-time RT-PCR analysis of total RNA isolated from C57Bl/6 spleens (Figure 4B). Interestingly, no RNA related to IMERV-1 or IMERV-2 was detected in naive or immune-stimulated 129/Sv spleens (Figure 4B). Genomic IMERV-1 and IMERV-2 sequences were detected in C57Bl/6, DBA/2 and BALB/c mice, but were absent in 129/Sv mice (Table 1). These results corroborated the special status of 129/Sv mice with regard to their retroviral repertoire.
###end p 25
###begin title 26
Quantification of PrP-related RNA, MLV-related RNA (broad specificity), and IMERV-related DNA by real-time (RT-)PCR.
###end title 26
###begin p 27
Comparison of samples was made within sections defined by type of quantified nucleic acid. For the top sample of each section RNA or DNA abundance was arbitrarily set to 100%.
###end p 27
###begin title 28
PrP up-regulation in response to high MLV activity
###end title 28
###begin p 29
###xml 233 241 233 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 400 409 400 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s005">Figure S5</xref>
###xml 582 589 582 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001158-t001">Table 1</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
The IMERV deficiency and the missing splenic PrP up-regulation of 129/Sv mice pointed to a possible dependence of PrP up-regulation on MLV activity. We first tested this hypothesis in a cell culture model of 3T3 fibroblasts infected in vitro with MLV. Western blot analysis of cell lysates showed that MLV-propagating cells expressed significantly more PrP than non-infected control 3T3 fibroblasts (Figure S5). Thus, the presence or activity of MLV is associated with increased PrP expression. Importantly, this PrP increase was not correlated with an increase of PrP-related RNA (Table 1), suggesting that a mechanism independent of transcription was involved. Correspondingly, in mice splenic PrP was up-regulated posttranscriptionally after immune-stimulation [16]. This indicated that PrP up-regulation occurred more specifically than just by broad gene activation in response to viral burden.
###end p 29
###begin p 30
###xml 139 148 139 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figure 2C</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 124 127 <span type="species:ncbi:11276">VSV</span>
We examined splenic PrP expression and the presence of MLV p30 over 14 days following immune-stimulation of C57Bl/6 mice by VSV infection (Figure 2C). Retroviral p30 increased at day 5 post-infection, peaked around day 8 and decreased again by day 14. Increased PrP expression was detected by day 8 and persisted beyond day 14. Thus, the kinetics was in line with the assumption that splenic PrP up-regulation occurred in response to IMERV, but also that increased PrP expression might be linked to IMERV regression.
###end p 30
###begin title 31
Retrovirus regression in response to increased PrP expression
###end title 31
###begin p 32
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
If there was an inhibitory effect of up-regulated PrP on IMERV, then PrP-deficient mice should show sustained IMERV activity. To address this subject, Prnp knockout mice were assessed for the presence of IMERV and their clearance kinetics.
###end p 32
###begin p 33
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>0/0</sup></italic>
###xml 25 29 25 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Bueler2">[14]</xref>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001158-t001">Table 1</xref>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp</italic>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Sakaguchi1">[18]</xref>
###xml 495 504 495 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g002">Figure 2D</xref>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g003">3</xref>
###xml 846 849 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 842 849 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>&#8722;/&#8722;</sup></italic>
###xml 1156 1159 1156 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1152 1159 1152 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>&#8722;/&#8722;</sup></italic>
###xml 1249 1253 1249 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Rossi1">[19]</xref>
###xml 1380 1383 1380 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1376 1383 1376 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>&#8722;/&#8722;</sup></italic>
###xml 1552 1555 1552 1555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1548 1555 1548 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>&#8722;/&#8722;</sup></italic>
###xml 1582 1585 1582 1585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1578 1585 1578 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>+/&#8722;</sup></italic>
###xml 1643 1646 1643 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1639 1646 1639 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>&#8722;/&#8722;</sup></italic>
###xml 1714 1723 1714 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001158.s006">Figure S6</xref>
###xml 1795 1798 1795 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1791 1798 1791 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>+/&#8722;</sup></italic>
###xml 1851 1860 1851 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001158-g004">Figure 4C</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 480 483 <span type="species:ncbi:11276">VSV</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1393 1397 <span type="species:ncbi:10090">mice</span>
###xml 1565 1569 <span type="species:ncbi:10090">mice</span>
###xml 1656 1660 <span type="species:ncbi:10090">mice</span>
###xml 1802 1806 <span type="species:ncbi:10090">mice</span>
One line of Prnp0/0 mice [14], which were generated on a mixed 129/Sv-C57BL/6 background, did not show IMERV activity (data not shown) or proviral DNA (Table 1) and was therefore not further evaluated. In contrast, Prnp-/- Nagasaki mice were established on a pure C57BL/6 background [18] and found to be IMERV-competent. They were compared with C57Bl/6 wild-type mice (PrP- and IMERV-competent) and 129/Sv wild-type mice (PrP-competent, IMERV-deficient) on day 8 and day 30 after VSV infection (Figure 2D and 3). In 129/Sv spleens, no MLV p30 was detected at any time point and PrP expression remained low. C57BL/6 wild-type spleens revealed high MLV p30 and PrP presence on day 8, yet on day 30 the two proteins differed. While PrP expression was still high, MLV p30 expression had nearly vanished. In contrast, in C57BL/6 mice lacking PrP (Prnp-/- Nagasaki) MLV p30 was found enhanced on day 8 and stayed high at least until day 30. Hence, these results support our hypothesis that PrP up-regulation negatively controls the splenic presence of IMERV. An uncertainty about the correct interpretation, however, was caused by the known particularity of Prnp-/- Nagasaki mice to ectopically express Doppel protein (Dpl), a PrP paralogue, in the brain [19]. Conceivably, Dpl may as well be ectopically expressed in the splenic FDC network, and if so, the persistence of IMERV in Prnp-/- Nagasaki mice might not be the result of PrP absence but of Dpl presence. Immunohistochemistry indeed revealed that Dpl was expressed in the splenic FDC network of Prnp-/- Nagasaki mice. In the Prnp+/- F1 generation of a crossing of C57Bl/6 wild-type and Prnp-/- Nagasaki mice, both PrP and Dpl were localized in the FDC network (Figure S6). This co-localization permitted us to show that PrP expression in Prnp+/- F1 mice restored the phenotype of IMERV regression (Figure 4C) irrespective of a putative role of splenic Dpl in IMERV activity.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
The present study has revealed that PrP up-regulation occurring in the mouse spleen after immune-stimulation coincides and co-localizes with the transient appearance of endogenous MLV (IMERV). Because PrP up-regulation did not occur in mice that lack the respective IMERV, and in turn, IMERV persisted in the spleen of mice without PrP expression, we conclude that splenic PrP expression plays a crucial role in the negative feedback control of immune-activated endogenous MLV.
###end p 35
###begin p 36
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Leblanc1">[20]</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Leblanc1">[20]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Gabus1">[21]</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Mironov1">[22]</xref>
###xml 1346 1354 1346 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1359 1366 1359 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1374 1378 1374 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Leblanc2">[23]</xref>
###xml 1379 1383 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Lee1">[25]</xref>
###xml 1649 1653 1649 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Baker1">[26]</xref>
###xml 2409 2415 2409 2415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 2643 2646 2643 2646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Deleault1">[5]</xref>
###xml 356 361 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 377 382 <span type="species:ncbi:9606">human</span>
###xml 525 530 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1339 1345 <span type="species:ncbi:10090">murine</span>
Whether PrP expression and retroviral activity are similarly interconnected in non-splenic tissues and other mammalian species remains to be determined, yet, support for such an assumption is provided by cell culture experiments. Over-expression of PrP counteracted the formation of endogenous MLV in N2a neuroblastoma cells (data not shown) and repressed HIV-1 in an infected human cell line [20]. These findings also indicate that the antiretroviral function of PrP might rely on cell-autonomous mechanisms. In the case of HIV-1 repression PrP was reported to interfere with the synthesis of distinct viral proteins on the level of translation [20], implying an interaction with retroviral RNA. In support of such an interaction, functional binding of PrP to retroviral RNA was demonstrated in a cell-free system [21], and PrP was found to be present not only in cell membranes but also in the cytosol [22]. Although PrP binding to retroviral RNA in mammalian cells waits to be confirmed, it is consistent with the concept of PrP and RNA partnering in TSE as summarised in the Introduction. We propose that PrP binding to retrovirus-related RNA is crucial for the antiretroviral effect of PrP expression as well as the pathophysiology of TSE. The latter may explain the interactions observed between TSE and (endogenous) retroviruses in murine in vitro and in vivo models [23]-[25]. The involvement of retrovirus-related RNA in TSE might also account for the activation pattern of microglia that was found to be reminiscent of an inflammatory response to latent or persistent viruses rather than to amyloidogenic proteins (including abnormal PrP) [26]. Besides the combined evidence for an involvement of retrovirus-related RNA in TSE, it is worth mentioning that in mammals this RNA species occurs ubiquitously, on occasion abundantly, and in various sizes (down to the range of small interfering RNA). Omnipresence or small size could be reasons why no TSE-specific RNA was identified so far. In addition, RNA species can adopt various conformations, and therefore, tissue preparations containing (enriched) TSE infectivity may fail to show TSE-specific ribonucleotide sequences because TSE specificity is imprinted in the secondary structure. According to our model, in which interacting PrP and RNA both can assume TSE-related conformations, principally either binding partner might be able to initiate per se propagation of the TSE agent. For the maintenance of propagation and strain characteristics, however, we assume the interaction of both components, PrP and RNA, to be required (in accordance with the results of Deleault et al. [5]).
###end p 36
###begin p 37
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Moroni1">[27]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Nelson1">[28]</xref>
###xml 881 885 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-White1">[29]</xref>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Corcoran1">[31]</xref>
###xml 1020 1024 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-White1">[29]</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
The massive appearance of IMERV in the FDC network of the mouse spleen is a remarkable finding by itself. Because IMERV activity occurred in response to various immune-stimuli and in several inbred mouse strains, it may be a common trait with physiological functions. Evidence for a connection between endogenous C-type viruses and the humoral immune response of mice was reported already three decades ago [27]. Since then, diverse immunological roles have been discussed for endogenous retroviruses [28] and we may speculate that IMERV activity likewise can provide antiviral resistance or modulate immune responses. The absence of genomic IMERV sequences and IMERV activity, as reported here for 129/Sv mice, might therefore be associated with immunological aberrations. Indeed, mice of the 129 strain show deficits in macrophage recruitment as well as NK and B cell activation [29]-[31]. The causes of these deficiencies have remained elusive, however, the macrophage impairment was reported to be a polygenic trait [29], which might be consistent with the absence of IMERV-related genes.
###end p 37
###begin p 38
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Lower1">[32]</xref>
###xml 434 442 434 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Leblanc1">[20]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Gabus1">[21]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Adler1">[33]</xref>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
Regarding the putative immunological impact of IMERV, control of IMERV-like activity may be important, all the more since retroviral activity in general increases the risks of insertional modifications of the genome or the emergence of new retroviral pathogens [32]. The PrP function suggested here might well extend to the control of further retroviral elements in addition to IMERV, as indicated by the potential of PrP revealed in in vitro studies [20], [21], [33]. Still, for individual animals the restriction of retroviral activity by PrP might be dispensable, like any proposed role of PrP, as implicated for instance by the viability of inbred PrP-deficient laboratory mice. However, it might be vital at the species level to limit risks posed by the activity of endogenous retroviral elements.
###end p 38
###begin p 39
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
In summary, our experiments have revealed, by correlation, a crucial role of PrP expression in the limitation of a common, but previously unrecognized, phenomenon in the mouse spleen, namely the massive activity of endogenous retroviruses in germinal centers after various immune-stimulations. The biological significance of transient retroviral activity in the spleen and anti-retroviral PrP function remains to be established. Yet, our findings offer an intriguing new viewpoint from which the conceptual conflicts thus far associated with PrP function and TSE pathophysiology may be resolved.
###end p 39
###begin title 40
Materials and Methods
###end title 40
###begin title 41
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 41
###begin p 42
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o/o</sup>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>o/o</sup></italic>
###xml 436 439 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 432 439 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prnp<sup>&#8722;/&#8722;</sup></italic>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
All mice were bred and maintained under SPF-conditions and experiments performed in accordance with institutional and Swiss-national guidelines. Wild-type C57BL/6 and 129/Sv mice were purchased from the Institute of Laboratory Animals (Vetsuisse Faculty, University of Zurich, Switzerland). DBA/2 and BALB/c mice were obtained from Harlan Netherlands (Horst, Netherlands). Prnpo/o (Zurich line, mixed C57BL/6x129/Sv background) and Prnp-/- (Nagasaki line, C57BL/6) mice were kindly provided by Adriano Aguzzi (Institute of Neuropathology, University of Zurich, Switzerland).
###end p 42
###begin title 43
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Virus infection of mice
###end title 43
###begin p 44
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 3 <span type="species:ncbi:11276">VSV</span>
###xml 13 16 <span type="species:ncbi:11276">VSV</span>
###xml 84 88 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 249 253 <span type="species:ncbi:10090">Mice</span>
###xml 306 310 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
VSV-Indiana (VSV-IND) growth and infection were performed as described before [16]. LCMV strain WE was originally obtained from Fritz Lehmann-Grube (Heinrich Pette Institute, University of Hamburg, Germany) and propagated on L929 and/or MC57 cells. Mice were infected with 2x102 plaque forming units (PFU) LCMV-WE injected intravenously as indicated. To avoid immune-pathological destruction of splenic microarchitecture, mice were depleted of CD8+ T cells prior to LCMV infection by monoclonal antibody (YTS 169.4) as previously described.
###end p 44
###begin title 45
Non-viral immune-stimulation
###end title 45
###begin p 46
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 235 238 <span type="species:ncbi:11276">VSV</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
Mice were immunized intravenously with IC, as previously described [16], or with LPS (15 microg intravenously/mouse; DIFCO Laboratories, Detroit, USA). 1.5ml thioglycolate 3% (DIFCO 0256-17) was administered intraperitoneally. Because VSV infection was the most efficient immune-stimulus for C57Bl/6 mice, it was chosen for comparative experiments comprising other mouse strains. Successful immune-stimulation was associated with significantly increased spleen net weight, in comparison to naive controls of the same experimental series, and was readily achieved with C57Bl/6, DBA/2, 129/Sv and the Prnp knockout mice. However, BALB/c mice exhibited increased spleen weight in only one out of two experimental series. BALB/c data of the successful series are shown.
###end p 46
###begin title 47
Electron microscopy
###end title 47
###begin p 48
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Tokuyasu1">[34]</xref>
###xml 1012 1016 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 1112 1116 1112 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Evans1">[35]</xref>
###xml 1453 1457 1453 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Tokuyasu1">[34]</xref>
###xml 5 10 <span type="species:ncbi:10090">mouse</span>
###xml 996 1002 <span type="species:ncbi:9986">rabbit</span>
###xml 1082 1085 <span type="species:ncbi:10116">rat</span>
###xml 1139 1145 <span type="species:ncbi:9986">rabbit</span>
###xml 1151 1154 <span type="species:ncbi:10116">rat</span>
From mouse spleens that were perfusion-fixed with 4% formaldehyde and 0.1% glutaraldehyde small pieces of white pulp were dissected. For plastic embedding, white pulp samples were post-fixed in 1% glutaraldehyde over-night and subjected to standard procedures of osmification, dehydration and Epon embedding. Ultrathin plastic sections were picked up on copper grids and contrasted with uranyl acetate and lead citrate. For immunogold-TEM white pulp samples were immersed for 48 h in 2 M sucrose containing 15% polyvinyl pyrrolidone (10 kDa; Sigma), mounted on aluminum pins and frozen and stored in liquid nitrogen. Ultrathin cryosections were prepared according to Tokuyasu [34] and picked up on nickel grids. Incubation of sections was performed by floating the grids on droplets of the respective solution. Immunolabelling was carried out with specific antibodies diluted in conditioning buffer (PBS containing 0.5% milk powder and 0.02% Tween). PrP-specific immunostaining was achieved with rabbit serum XN [16] at a dilution of 1:200. MLV Env-specific immunostaining employed rat monoclonal antibody 83A25 [35] at 1:2 and subsequent rabbit-anti rat (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) at 1:300. Antibody binding was indirectly gold-labeled by incubation with 8- and 12-nm gold-complexed protein A, respectively. Immunolabelled sections were embedded and stained with methylcellulose and uranyl acetate according to Tokuyasu [34]. Micrographs were taken on a Zeiss EM 910.
###end p 48
###begin title 49
Immunohistochemistry
###end title 49
###begin p 50
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 304 310 <span type="species:ncbi:9986">rabbit</span>
###xml 351 354 <span type="species:ncbi:10116">rat</span>
###xml 396 400 <span type="species:ncbi:9925">goat</span>
###xml 532 536 <span type="species:ncbi:9925">goat</span>
###xml 674 678 <span type="species:ncbi:9925">goat</span>
Semithin sections of 400 nm were prepared from sucrose-infiltrated aldehyde-fixed spleen tissue as for ultrathin cryotomy. Preparation of cryostat sections from non-fixed spleen samples and immunostaining were carried out as previously described [16]. Primary antibodies were the following: PrP-specific rabbit antiserum XN at 1:600, MLV Env-specific rat antibody 83A25 at 1:3, MLV gp71-specific goat serum (kindly provided by Roland Friedrich, Microbiology and Virology, University of Giessen, Germany) at 1:3000, MLV p30-specific goat serum (kindly provided by Hans Lutz, Vetsuisse Faculty, University of Zurich, Switzerland) at 1:1500, and Dpl-specific affinity-purified goat antibody Dpl (G-20) (Santa Cruz Biotechnology Inc., Santa Cruz, CA) at 1:50.
###end p 50
###begin title 51
Western blot and PERT analysis
###end title 51
###begin p 52
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Boni1">[36]</xref>
###xml 221 227 <span type="species:ncbi:9986">rabbit</span>
For Western blot analysis, spleen tissue and cell culture sample preparations, electrophoresis and immunoblot detection were performed as decribed previously [16]. Employed primary antibodies were PrP-specific polyclonal rabbit antibody 1B3 [16] at 1:5000, and MLV p30-specific antibody at 1:10'000. For determination of splenic reverse transcriptase activity, 10% homogenates of spleen samples prepared for Western blot analysis were diluted 1:1000 and subjected to PERT assays as described elsewhere [36] (making use of a modification for real-time detection).
###end p 52
###begin title 53
Cell culture experiments
###end title 53
###begin p 54
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
###xml 235 236 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse fibroblasts of the 3T3-Swiss albino cell line were cultured as described previously [16]. For infection with Moloney type MLV culture medium was complemented 1:2 with 0.45mum-filtered virus-containing supernatant with a titer >107 pfu/ml (viral stock kindly provided by Tatiana Afanasieva, Institute of Neuropathology, University of Zurich, Switzerland) and 8 microg/ml polybrene (Sigma). Medium was exchanged the next morning. Mock-infected and MLV-infected fibroblast cultures were passaged after 3 days and harvested on day 5 for Western blot analysis.
###end p 54
###begin title 55
Specific MLV particle isolation
###end title 55
###begin p 56
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 90 95 <span type="species:ncbi:9940">sheep</span>
###xml 101 104 <span type="species:ncbi:10116">rat</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 661 664 <span type="species:ncbi:10116">rat</span>
An approximate amount of 4x107 paramagnetic beads (Dynabeads M450) with covalently linked sheep anti-rat IgG (Dynal Biotech, Oslo, Norway) was washed, resuspended in 800 microl PBS/0.1%BSA and added to 1 ml of MLV Env-specific supernatant 83A25 for incubation over-night at 4degreesC to obtain MLV-specific beads. A 20% homogenate of immune-stimulated mouse spleen tissue was prepared in 10 mMTris-HCl pH 7.5 supplemented with 1 mM EDTA, 100 mM NaCl and 5% sucrose. The homogenate was centrifuged for 30 min at 10'000g and 4degreesC, and 0.5 ml of the supernatant was added to washed MLV-specific beads (or, as a negativ control, to an equal amount of original rat IgG-specific beads) and incubated for 2 h at ambient temperature. After incubation beads were collected, washed and processed either for Epon embedding, ultrathin sectioning (100 nm) and EM examination, or for RNA isolation.
###end p 56
###begin title 57
RNA and DNA extraction
###end title 57
###begin p 58
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</italic>
Total RNA from paramagnetic bead fractions, spleens, or cells was obtained by direct lysis of the samples in TRI reagent (MRC Inc.) and further processing according to the manufacturers protocol. Putative traces of contaminating DNA were removed with DNA-freetrade mark Kit (Ambion Inc.).
###end p 58
###begin p 59
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
DNA was extracted from mouse tail, spleen or brain by decomposing tissue in tail lysis solution over-night at 55degreesC. After brief centrifugation of the lysate, DNA was precipitated from the supernatant with isopropanol. Precipitate was washed with 70% ethanol, air-dried and reconstituted in 50 mM Tris-HCl pH 8.
###end p 59
###begin title 60
Reverse transcription and PCR amplification
###end title 60
###begin p 61
Reverse transcription on RNA extracted from paramagnetic bead fractions was performed using the SuperScripttrade mark First-strand Synthesis System for RT-PCR (Invitrogen) with random hexameric primers according to the manufacturers instructions. Subsequent PCR amplification employed the following primers: forward 5'-ataacccagggacctaatgagtc-3' for broad Friend-MLV genome-related specificity, forward 5'-ataacacaagggcccaatga-3' for broad Moloney-MLV genome-related specificity, and reverse 5'-cttccacccgcttgttga-3' for both of them.
###end p 61
###begin title 62
Cloning and sequencing
###end title 62
###begin p 63
###xml 180 187 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 180 187 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
PCR products were isolated and purified with the QIAquick Gel Extraction Kit (Qiagen). Cloning was performed by use of the pGEM(R)-T Easy Vector System kit (Promega) and competent E. coli JM109 cells (Promega). Plasmids were purified with the Plasmid Midi Kit (Qiagen) and the inserts sequenced on an ABI 377 sequencer using Big Dye terminator chemistry (Applied Biosystems) and custom primers.
###end p 63
###begin title 64
RNA and DNA quantification by real-time PCR
###end title 64
###begin p 65
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001158-Ltscher1">[16]</xref>
Real-time RT-PCR analysis of RNA was performed as described previously for GAPDH (internal standard) and PrP-related RNA [16]. The primer-probe set with broad specificty for MLV was: forward 5'-aagcgggtggaagacatcc-3', reverse 5'-agcccgctcaagaggttgt-3', probe FAM-5'-ccccaccgtgcccaaccct-3'-TAMRA. The primer-probe set specific for IMERV-1 was: forward 5'-cactttgagggatcaggagcc-3', reverse 5'-cttctaggtttagggtcaacacctgt-3', probe FAM-5'-aggttgtgggaccaaaaggacagcc-3'-TAMRA. For IMERV-2-related RNA, the set was: forward 5'-cacttcgagggatcgggagct-3', reverse 5'-cctctatgccaagggtcaacacctgc-3', same probe as for IMERV-1.
###end p 65
###begin p 66
The procedure for real-time PCR analysis of DNA was identical to the one for RNA analysis except that the template nucleic acid was 5 ng DNA per reaction and the reverse transcription step was omitted.
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin p 68
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
TEM of ultrathin cryosections through the germinal center of a mouse spleen showing an FDC (F) with its labyrinthine extensions between lymphocytes (L). The wild-type mouse of the C57Bl/6 strain was immune-stimulated 8 days before by intravenous IC. PrP-specific immunogold labelling (small black dots) is restricted to the FDC extensions. Retrovirus-like particles can also be discerned, with the morphology of mature (arrows) and immature budding virus (arrowhead). Bar, 500 nm.
###end p 68
###begin p 69
(1.40 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 162 165 <span type="species:ncbi:11276">VSV</span>
Immunofluorescence staining obtained with antibodies directed against MLV Env, gp71 and p30 on consecutive cryosections of spleens of C57Bl/6 mice on day 8 after VSV infection. On each section double-staining revealed the MLV protein in conjunction with PrP. Bar, 100 mum.
###end p 71
###begin p 72
(0.09 MB PDF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Correspondence of mature MLV p30 abundance and reverse transcriptase (RT) activity in mouse spleens. Homogenates from naive (first from the left) and immune-stimulated C57BL/6 spleens were analysed by Western blot for the p30 protein band at the 30 kDa position (immunoblots at bottom) and by PERT assay for RT activity.
###end p 74
###begin p 75
(0.05 MB PDF)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
Isolation and amplification of immune-activated MLV-related RNA sequences. (A) Immunoabsorptive isolation of viral particles. Paramagnetic beads were incubated in homogenate of immune-stimulated C57BL/6 spleens, washed and then processed for RNA isolation or for visual control by TEM. Electron micrographs of ultrathin plastic sections show beads without specificity for MLV (left panel), and the surface of an Env-specific bead with bound viral particles (right panel). Bar, 1 mum. (B) MLV-specific RT-PCR products obtained with RNA preparations from immunoabsorptive bead samples. Reverse transcription and amplification of RNA from cultivated Moloney MLV (positive control, lane 1), from non-specific bead samples (lanes 2 and 4) and from Env-specific bead samples (lanes 3 and 5) were performed with primer pairs specific for Moloney type (lanes 1-3) and for Friend type MLV sequence (lanes 4 and 5), respectively. Visible bands (lanes 1 and 5) represent products of the expected size of 1.3 kilobases. Marker, lane 6.
###end p 77
###begin p 78
(0.14 MB PDF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Increased PrP and p30 expression by 3T3 fibroblasts following infection with Moloney MLV. Retrovirus infection was established within 5 days with cell passage in fresh medium. Per experimental group, i.e. control cells (- MLV) and infected cells (+MLV), lysates of three cell cultures were pooled for analysis in the presented Western blots, in order to obtain averaged results.
###end p 80
###begin p 81
(0.03 MB PDF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 194 197 <span type="species:ncbi:11276">VSV</span>
Dpl and PrP expression in splenic FDC networks of Prnp-/- (Nagasaki), C57Bl/6 wild-type Prnp+/+ mouse and F1 offspring of Prnp-/- (Nagasaki)/C57Bl/6 wild-type crossing (Prnp+/-), on day 8 after VSV infection. Dpl and PrP were revealed by immunofluorescence double-staining. Bar, 100 mum.
###end p 83
###begin p 84
(0.09 MB PDF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:9925">goat</span>
###xml 253 257 <span type="species:ncbi:9925">goat</span>
###xml 322 325 <span type="species:ncbi:10116">rat</span>
We wish to thank Bruno Guhl, Lucia Bertodatto and Ursula Schaub for technical assistance, Adriano Aguzzi for providing PrP-deficient mice and PrP-specific antibodies, Roland Friedrich for MLV gp71-specific goat antiserum, Hans Lutz for MLV p30-specific goat antiserum, Tatiana Afanasieva for MLV stock and Frank Malik for rat antibody 83A25.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
Introduction to the transmissible spongiform encephalopathies or prion diseases.
###end article-title 88
###begin article-title 89
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice devoid of PrP are resistant to scrapie.
###end article-title 89
###begin article-title 90
Prions.
###end article-title 90
###begin article-title 91
Prions and their partners in crime.
###end article-title 91
###begin article-title 92
From the Cover: Formation of native prions from minimal components in vitro.
###end article-title 92
###begin article-title 93
RNA molecules stimulate prion protein conversion.
###end article-title 93
###begin article-title 94
Structural determinants of conformationally selective, prion-binding aptamers.
###end article-title 94
###begin article-title 95
RNA aptamers specifically interact with the prion protein PrP.
###end article-title 95
###begin article-title 96
A 'unified theory' of prion propagation.
###end article-title 96
###begin article-title 97
Reciprocal interference between specific CJD and scrapie agents in neural cell cultures.
###end article-title 97
###begin article-title 98
The cellular prion protein (PrP(C)): Its physiological function and role in disease.
###end article-title 98
###begin article-title 99
Nearly ubiquitous tissue distribution of the scrapie agent precursor protein.
###end article-title 99
###begin article-title 100
Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein.
###end article-title 100
###begin article-title 101
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.
###end article-title 101
###begin article-title 102
###xml 14 20 <span type="species:ncbi:9913">cattle</span>
Production of cattle lacking prion protein.
###end article-title 102
###begin article-title 103
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: follicular dendritic cells versus capsule and trabeculae.
###end article-title 103
###begin article-title 104
###xml 66 87 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 120 132 <span type="species:ncbi:10090">Mus musculus</span>
Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus.
###end article-title 104
###begin article-title 105
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent.
###end article-title 105
###begin article-title 106
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain.
###end article-title 106
###begin article-title 107
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:9606">Human</span>
Analysis of the Interactions Between HIV-1 and the Cellular Prion Protein in a Human Cell Line.
###end article-title 107
###begin article-title 108
###xml 108 113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1.
###end article-title 108
###begin article-title 109
Cytosolic prion protein in neurons.
###end article-title 109
###begin article-title 110
Retrovirus infection strongly enhances scrapie infectivity release in cell culture.
###end article-title 110
###begin article-title 111
###xml 27 55 <span type="species:ncbi:35275">murine endogenous retrovirus</span>
Prion infection influences murine endogenous retrovirus expression in neuronal cells.
###end article-title 111
###begin article-title 112
###xml 85 106 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 108 112 <span type="species:ncbi:11786">MuLV</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:11786">MuLV</span>
Scrapie infection activates the replication of ecotropic, xenotropic, and polytropic murine leukemia virus (MuLV) in brains and spinal cords of senescence-accelerated mice: implication of MuLV in progression of scrapie pathogenesis.
###end article-title 112
###begin article-title 113
Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease.
###end article-title 113
###begin article-title 114
Are endogenous C-type viruses involved in the immune system?
###end article-title 114
###begin article-title 115
###xml 13 18 <span type="species:ncbi:9606">Human</span>
Demystified. Human endogenous retroviruses.
###end article-title 115
###begin article-title 116
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment.
###end article-title 116
###begin article-title 117
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice.
###end article-title 117
###begin article-title 118
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
IL-5 and Rp105 signaling defects in B cells from commonly used 129 mouse substrains.
###end article-title 118
###begin article-title 119
The pathogenic potential of endogenous retroviruses: facts and fantasies.
###end article-title 119
###begin article-title 120
###xml 63 68 <span type="species:ncbi:9606">human</span>
Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro.
###end article-title 120
###begin article-title 121
Immunochemistry on ultrathin frozen sections.
###end article-title 121
###begin article-title 122
###xml 115 138 <span type="species:ncbi:11786">murine leukemia viruses</span>
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.
###end article-title 122
###begin article-title 123
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The work was supported in part by grants from the Swiss National Science Foundation, the Novartis Stiftung, the EMDO Stiftung Zurich, and the Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft (all to ML).
###end p 125

